NASDAQ · Analyst Forecast

SCYNEXIS, Inc. (SCYX) Stock Forecast & Price Target

$2.85 NASDAQ: SCYX Market Cap $17.92M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering SCYNEXIS, Inc. (SCYX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For SCYNEXIS, Inc., analysts forecast revenue rising from $9.94M in 2025 to $27.60M in 2030; the average estimate for 2030 earnings per share is −$2.96; with published estimates ranging from −$5.37 to −$1.29; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$5.63M$9.94M$16.18M2
2026$222,729$393,333$639,9482
2027$3.69M$6.52M$10.61M2
2028$6.54M$14.08M$20.73M3
2029$7.15M$12.63M$20.56M1
2030$15.63M$27.60M$44.91M2

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$4.55−$2.51−$1.092
2026−$5.68−$3.13−$1.372
2027−$3.55−$1.95−$0.852
2028−$3.00−$1.73−$0.873
2029−$4.68−$2.58−$1.131
2030−$5.37−$2.96−$1.292

SCYNEXIS, Inc. (SCYX) forecast — frequently asked questions

What are analysts forecasting for SCYNEXIS, Inc.'s earnings?

The average analyst estimate for SCYNEXIS, Inc. (SCYX) earnings per share in 2030 is -2.96, with individual estimates between -5.37 and -1.29.

How much revenue is SCYNEXIS, Inc. expected to make?

Analysts forecast SCYNEXIS, Inc. (SCYX) revenue of $27.60M in 2030, based on 2 published estimates.

How many analysts cover SCYX?

3 analysts contribute estimates for SCYNEXIS, Inc. (SCYX). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Pharmaceuticals stocks

RPRX forecastCORT forecastLQDA forecastPBH forecastQUIT forecastHITI forecastETRA stockTRXB stockAll Medical - Pharmaceuticals stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.